Clinical Trial Update: Panitumumab in Combination With Radiotherapy in Patients With Locally Advanced RAS Wildtype Rectal Cancer (Clinical Stages II and III) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating panitumumab in combination with radiotherapy for locally advanced, RAS wildtype rectal cancer (stages II–III).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: WiSP Wissenschaftlicher Service Pharma GmbH | Conditions: Rectal Cancer | Phase 2 | Status: UNKNOWN